Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Drosophila melanogaster
Entry Details
ID
4793
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
Q04164 (Created: 2002-11-15 Updated: 2008-12-16)
UniProtKB/Swiss-Prot Entry Name
SAS_DROME
Protein Name
Putative epidermal cell surface receptor
Gene
sas
Organism Scientific
Drosophila melanogaster
Organism Common
Fruit fly
Lineage
Eukaryota
Metazoa
Arthropoda
Hexapoda
Insecta
Pterygota
Neoptera
Endopterygota
Diptera
Brachycera
Muscomorpha
Ephydroidea
Drosophilidae
Drosophila
Sophophora
Protein Length [aa]
1693
Protein Mass [Da]
185254
Features
Type
Description
Status
Start
End
signal peptide
potential
1
41
chain
Putative epidermal cell surface receptor
42
1693
transmembrane region
potential
1636
1656
topological domain
Extracellular
potential
42
1635
topological domain
Cytoplasmic
potential
1657
1693
domain
VWFC 1
663
708
domain
VWFC 2
828
902
domain
Fibronectin type-III
1411
1501
glycosylation site
N-linked (GlcNAc...)
potential
106
106
glycosylation site
N-linked (GlcNAc...)
potential
109
109
glycosylation site
N-linked (GlcNAc...)
potential
330
330
glycosylation site
N-linked (GlcNAc...)
potential
473
473
glycosylation site
N-linked (GlcNAc...)
potential
538
538
glycosylation site
N-linked (GlcNAc...)
potential
622
622
glycosylation site
N-linked (GlcNAc...)
potential
685
685
glycosylation site
N-linked (GlcNAc...)
potential
827
827
glycosylation site
N-linked (GlcNAc...)
potential
846
846
glycosylation site
N-linked (GlcNAc...)
potential
929
929
glycosylation site
N-linked (GlcNAc...)
potential
939
939
glycosylation site
N-linked (GlcNAc...)
potential
1323
1323
glycosylation site
N-linked (GlcNAc...)
potential
1419
1419
glycosylation site
N-linked (GlcNAc...)
potential
1517
1517
splice variant
(in isoform Short)
930
1274
compositionally biased region
Thr-rich
51
377
compositionally biased region
Cys-rich
534
901
compositionally biased region
Glu/Pro-rich
997
1273
SP Length
41
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MQTCRRRKASGGQSTIKWSRMCLATLCGLLLLGIQIERAAS
Sequence
MQTCRRRKASGGQSTIKWSRMCLATLCGLLLLGIQIERAAS
APAGEDAAA
TTMPPLDTTTDAPDAVAATTTPATTAAEQSSSISSITTEAADGSTTSTTT
TTEAANKSNATETDFTTNVPVASSLPEETSVRSTSIEPITSTEPTTTPRQ
ETEGPDQHMVFSNTEPDQSHIQHIPLRDEHAESSGADDATTEMQRQREQD
QQQNELNQISNEQDDVVKDLNNFRHPATLITASNSNSEENVEIESDKQVE
TTTTAVPAAATSTSTEATGTPPTGTPATSTSTVPNEREEDPYHVHILSEN
HDRLAEHEDYQMLSTSTEESSTTSTTSTTNSTTESGIVAGIVVSQENKAT
AEPSTATESTSISTSTTTAATAATSTT
SRARAMHMNDPEDEAATTIMPDS
ESVPVINIVEGQHMLQQEDQKDEEEEGVVKESESSSTTEASTTTTEPSPF
VAFAGEGRSAGGGNDIELFLHH
N
GSTHEQLMDLSDVSMDGDQNEGSSKTE
SSTTSTTTTTAQPETEMPKIVEITASGDTMQRE
CLANNKSYKHGELMERD
CDERCTCNRGDWMCEPRCRGLSYPRGSQRSMANPNCLEKMVEEDECCRVM
ECSEPQLEPTVVATEGAAPSTNGTGESAVTLPTTDDEATPKPRTDCHYNS
GVYKFRERLEIGCEQICHCAEGGVMDCRPRCPERNHTRLDKCVYVKDPKD
VCCQLELCDVTLDDHEQQPTPLQSNNNEDPEEIDPFRFQEQARDAGGAKP
TCTFKGAEYDVGQQFRDGCDQLCICNEQGIHCAKLECPSNFGLDVQDPHC
IRWEPVPADFKPSPPNCCPESMRCVDNGTCSYQGVQIENWSPVPANLTGC
DQHCYCENGRVECRAACPPVPALPPADLPCHPALARLLPIPDDECCKHWM
C
A
PQIPKIGGAGQDEETEATSTHSSIPA
N
ETTTTTATANKSTSIPSKVPQ
IKKDEEKRPPASGAFYPTLDGKPPKSIGGLGIFEKPEKPEKAHKKV
QHQQ
QQHQQQEQQEQQQHQNDVIFDGDRTEEQEEPLPPNGGFVPFQFGQQHPHQ
PHLGPYGFYNPVKPVYEDYNPYEPYDINPNGTPQGKPPPVPTSQSDLFNI
LGAEQPGHPVHPGHGGPPRIHPGQTQKDNHNLGPQVRIEQILQHLQQTVP
GGPPPPPPHQQHQSLTPQLHPQQQQISQQHPGHYVPIVHSGVPPPPPGHG
IAIVDGQTVAYESYPVIPGLGVPQHHPQQHQTTPQQHLQQTILPSSSTTS
GLSTQASEHSLHQNQGKLAKQQQ
S
GANNLQPDIEVHTLEAIDPRSIRIVF
TVPQVYVNLHGRVELRYSNGPS
N
DTSTWEQQIFAPPEDLIATSQMEFDLP
SLEPNSLYKVKITLILRDLNSQPTSSIYTVKTPPERTITPPPPFPDYRPD
FQDIFKNVED
PELTVSET
N
ASWLQLTWKKLGDDQMEYVDGVQLRYKELTG
MIYSSTPLIHRTLTSYTIQNLQPDTGYEIGLYYIPLAGHGAELRAGHMIK
V
RTAQKVDVYGFDVTV
N
VTKVKTQSVEISWNGVPYPEDKFVHIYRAIYQS
DAGKEDSSVFKVAKRDSTTGTLIMDLKPGTKYRLWLEMYLTNGNTKKSNV
VNFITKPGGPATPGKTGKLLTAGTDQPVGDYYGPL
VVVSVIAALAIMSTL
ALLLII
TRRRVHQTASITPPRKSDAAYDNPSYKVEIQQETMNL
Original
MQTCRRRKASGGQSTIKWSRMCLATLCGLLLLGIQIERAASAPAGEDAAA
TTMPPLDTTTDAPDAVAATTTPATTAAEQSSSISSITTEAADGSTTSTTT
TTEAANKSNATETDFTTNVPVASSLPEETSVRSTSIEPITSTEPTTTPRQ
ETEGPDQHMVFSNTEPDQSHIQHIPLRDEHAESSGADDATTEMQRQREQD
QQQNELNQISNEQDDVVKDLNNFRHPATLITASNSNSEENVEIESDKQVE
TTTTAVPAAATSTSTEATGTPPTGTPATSTSTVPNEREEDPYHVHILSEN
HDRLAEHEDYQMLSTSTEESSTTSTTSTTNSTTESGIVAGIVVSQENKAT
AEPSTATESTSISTSTTTAATAATSTTSRARAMHMNDPEDEAATTIMPDS
ESVPVINIVEGQHMLQQEDQKDEEEEGVVKESESSSTTEASTTTTEPSPF
VAFAGEGRSAGGGNDIELFLHHNGSTHEQLMDLSDVSMDGDQNEGSSKTE
SSTTSTTTTTAQPETEMPKIVEITASGDTMQRECLANNKSYKHGELMERD
CDERCTCNRGDWMCEPRCRGLSYPRGSQRSMANPNCLEKMVEEDECCRVM
ECSEPQLEPTVVATEGAAPSTNGTGESAVTLPTTDDEATPKPRTDCHYNS
GVYKFRERLEIGCEQICHCAEGGVMDCRPRCPERNHTRLDKCVYVKDPKD
VCCQLELCDVTLDDHEQQPTPLQSNNNEDPEEIDPFRFQEQARDAGGAKP
TCTFKGAEYDVGQQFRDGCDQLCICNEQGIHCAKLECPSNFGLDVQDPHC
IRWEPVPADFKPSPPNCCPESMRCVDNGTCSYQGVQIENWSPVPANLTGC
DQHCYCENGRVECRAACPPVPALPPADLPCHPALARLLPIPDDECCKHWM
CAPQIPKIGGAGQDEETEATSTHSSIPANETTTTTATANKSTSIPSKVPQ
IKKDEEKRPPASGAFYPTLDGKPPKSIGGLGIFEKPEKPEKAHKKVQHQQ
QQHQQQEQQEQQQHQNDVIFDGDRTEEQEEPLPPNGGFVPFQFGQQHPHQ
PHLGPYGFYNPVKPVYEDYNPYEPYDINPNGTPQGKPPPVPTSQSDLFNI
LGAEQPGHPVHPGHGGPPRIHPGQTQKDNHNLGPQVRIEQILQHLQQTVP
GGPPPPPPHQQHQSLTPQLHPQQQQISQQHPGHYVPIVHSGVPPPPPGHG
IAIVDGQTVAYESYPVIPGLGVPQHHPQQHQTTPQQHLQQTILPSSSTTS
GLSTQASEHSLHQNQGKLAKQQQSGANNLQPDIEVHTLEAIDPRSIRIVF
TVPQVYVNLHGRVELRYSNGPSNDTSTWEQQIFAPPEDLIATSQMEFDLP
SLEPNSLYKVKITLILRDLNSQPTSSIYTVKTPPERTITPPPPFPDYRPD
FQDIFKNVEDPELTVSETNASWLQLTWKKLGDDQMEYVDGVQLRYKELTG
MIYSSTPLIHRTLTSYTIQNLQPDTGYEIGLYYIPLAGHGAELRAGHMIK
VRTAQKVDVYGFDVTVNVTKVKTQSVEISWNGVPYPEDKFVHIYRAIYQS
DAGKEDSSVFKVAKRDSTTGTLIMDLKPGTKYRLWLEMYLTNGNTKKSNV
VNFITKPGGPATPGKTGKLLTAGTDQPVGDYYGPLVVVSVIAALAIMSTL
ALLLIITRRRVHQTASITPPRKSDAAYDNPSYKVEIQQETMNL
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11